M1238
Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
- Release
- October 2026
- Effective
Version History
How M1238 appears in each release imported from the official files, newest first.
-
October 2026 Effective
CurrentDocumentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
-
July 2026 Effective
UnchangedDocumentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
-
April 2026 Effective
UnchangedDocumentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
-
January 2026 Effective
UnchangedDocumentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
Data Source
Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.
- Release
- October 2026
- Effective
- Source file
- october-2026-alpha-numeric-hcpcs-file.zip
Official HCPCS Level II source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.